Merck KGaA receives global marketing and commercialization rights to Genea Biomedx’s product portfolio
Merck Serono S.A., a biopharmaceutical company and subsidiary ofMerck KgaA, has entered into a global agreement with Genea Biomedx UK Ltd., an... Read More
Actavis got new drug approval for Viberzi
About Viberzi VIBERZI (eluxadoline) has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist, and a kappa... Read More
Abu Dhabi-based Neopharma’s generic drug production deal with Pfizer
Neopharma, the Abu Dhabi-based drug manufacturer, has tied up with a Pfizer unit to manufacture selected products. In partnership with Wyeth, Neopharma will... Read More
Sanofi to expand its generic portfolio in Middle East with acquisition of significant stake in Globalpharma
Sanofi has acquired a majority stake in Globalpharma from Dubai Investments as the French drug maker targets the booming regional pharmaceuticals sector.... Read More
Pharma emerging market is the latest strategic bet for the success
In recent years, there are several factors which causing pharmaceutical industry / companies to shrink their margins. Price and cost pressure, regulatory... Read More
Key pharmaceutical business region acronym
Followings are the key acronym which is used in pharmaceutical global business / international trade regularly. APAC: Asia-Pacific BENELUX: Belgium, Netherlands and Luxembourg.... Read More
Amgen exits Psoriasis Drug Brodalumab Deal with AstraZeneca
Amgen today announced the termination of its co-development and commercialisation agreement with AstraZeneca for brodalumab, an investigational IL-17 receptor inhibitor in development... Read More
Eureka Therapeutics Inc. and Boehringer Ingelheim Announce a Collaboration to Identify Next Generation Antibodies for Cancer Treatment
Eureka Therapeutics Inc. and Boehringer Ingelheim announced today that they have entered into a research agreement for the discovery of novel therapeutic... Read More
Strategic deal in talk – Cadila Healthcare to acquire Claris
Posted on22 May 2015
Comments0
Cadila Healthcare has come up as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL). As... Read More
Strides Arcolab to buy Aspen’s generics biz for Australian Dollar 380 million
Strides Pharma Global Pte. Ltd and Strides (Australia) Pharma Pty Ltd, Australia, both wholly-owned subsidiaries of Strides Arcolab have signed definitive agreement... Read More